Topics

Companies Related to "Phase I Clinical Study in the Treatment of HER2-positive Recurrent or Metastatic Breast Cancer.∨derfield=score∨derval=desc" [Most Relevant Company Matches] - Page: 3 RSS

13:44 EDT 21st July 2019 | BioPortfolio

Here are the most relevant search results for "Phase I Clinical Study in the Treatment of HER2-positive Recurrent or Metastatic Breast Cancer.∨derfield=score∨derval=desc" found in our extensive corporate database of over 50,000 company records.

Showing "Phase Clinical Study Treatment HER2 positive Recurrent Metastatic" Companies 51–75 of 8,400+

Monday 17th June 2019

Mycovia Pharmaceuticals, Inc

Mycovia Pharmaceuticals has a passion for developing breakthrough therapies in areas of unmet medical need. Our lead product candidate, VT-1161 (oteseconazole), is a novel, oral therapy designed to have greater selectivity, fewer side effects and improved potency than current treatment options. It received FDA Qualified Infectious Disease Product and Fast-...


Expansion Therapeutics, Inc.

Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Based on exclusive worldwide rights to groundbreaking research from the laboratory of Matthew D. Disney, Ph.D., at The Scripps Research Institute, Expansion has assembled the intellectual property, know-how, ...

Friday 14th June 2019

Amazentis SA

Amazentis SA is a life science company that employs today’s leading research and clinical science to develop the next generation of bioactive ingredients derived from nature for advanced therapeutic nutrition products. The Company’s lead product candidate, AMAZ-02, an oral formulation of Urolithin A, is planned to enter Phase 2 clinical testing d...


Thursday 13th June 2019

BioCell Technology, LLC

BioCell Collagen® is a clinically tested branded dietary ingredient that promotes active joints, youthful-looking skin, and healthy connective tissues. BioCell Collagen® contains a patented composition of naturally occurring hydrolyzed collagen type II peptides, chondroitin sulfate and hyaluronic acid in a highly absorbable matrix form that has been the ...

Wednesday 12th June 2019

Prelude Therapeutics

Prelude Therapeutics is a privately held, clinical-stage biopharmaceutical company based in Wilmington, DE. Prelude is focused on the discovery and development of small molecule agents targeting novel molecular mechanisms that drive cancer cell growth, survival and resistance to current treatments. For more information, please visit www.preludetx.com.

IMV IMV Inc.

IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of immunotherapies based on the Company’s proprietary drug delivery platform. This patented technology leverages a ...

Tuesday 11th June 2019

Ironshore Pharmaceuticals Inc.

The effectiveness of JORNAY PM was established in two separate Pivotal Phase III, multicenter, randomized, double-blind, placebo-controlled studies conducted in a total of 278 pediatric patients aged 6 to 12 years with a diagnosis of ADHD per DSM-5 criteria. In addition to the traditional scales that assess efficacy in ADHD clinical trials such as the Swan...

Orpheris

Orpheris is a clinical stage neuroscience company leveraging a novel platform technology from Johns Hopkins that enables the selective delivery of therapeutic agents across the blood barrier into reactive microglial cells. In a number of neurodegenerative diseases such as ALS, Parkinson's, and Alzheimer's, reactive microglia are shown to be responsible for...

Tarveda Therapeutics®, Inc.

Tarveda Therapeutics is a clinical stage biopharmaceutical company that is developing and discovering a new class of potent and selective precision oncology medicines for the treatment of patients with solid tumor malignancies. We are developing our proprietary Pentarin® miniature conjugates to enhance the effectiveness of promising anti-cancer payloads...

AlloVir

AlloVir (formerly ViraCyte), founded in 2013 by researchers at Baylor College of Medicine’s Center for Cell and Gene Therapy, is the leader in the development of novel cell therapies with a focus on restoring natural T-cell immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The company’s...

TrialAssure

TrialAssure is a global clinical trial disclosure and transparency reporting suite with unmatched experience in helping clients navigate complex regulatory submission and reporting challenges. TrialAssure helps meet regulatory compliance goals through a flexible, scalable, and streamlined platform that regularly adapts to ever-changing clinical trial discl...

Monday 10th June 2019

OrthoTrophix, Inc.

OrthoTrophix, Inc., based in Oakland, California, is a privately held biopharmaceutical company focused on the development and commercialization of revolutionary therapeutics for the treatment of diseases and conditions involving the hard tissues. Founded by three co-founders in 2011, the primary focus of OrthoTrophix has been regeneration and repair of ca...

Mary Kay Inc.

At Mary Kay, success lies in our dedication to irresistible products, a rewarding opportunity and positive community impact. For 55 years, Mary Kay has inspired women to achieve their entrepreneurial goals in nearly 40 countries. As a multibillion-dollar company, we offer the latest in cutting-edge skin care, bold color cosmetics and fragrances. Discover m...

Thursday 6th June 2019

Vivacelle Bio, Inc.

Vivacelle Bio, Inc. is a clinical stage biotechnology company that is focused on the discovery of new knowledge in the field of critical care and trauma. Currently, the company’s strategy is to develop and commercialize its discoveries that have led to a pipeline of products that are based on the biophysical properties of phospholipid nanoparticles an...

Wuhan General Group (China), Inc.

Wuhan General Group (China), Inc. through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company that researches, develops and commercializes a range of CBD-based products under the Dr. AnnaRx brand. In addition, its new division, M2BIO aims to explore and develop additional indications for psilocybin new therapies that will help ...

Current Health

Current Health help healthcare providers to intervene proactively at home and in hospital via continuous, wireless monitoring and precise early warning alerts. We monitor the human body in real-time. FDA-cleared and with ICU-level accuracy, we track more vital signs than any other all-in-one device. Today, we’re focused on helping healthcare providers...

Wednesday 5th June 2019

OncoMyx Therapeutics

OncoMyx Therapeutics, a startup launched from Arizona State University (ASU), develops oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer. Successful immuno-oncology (IO) cancer treatment generally requires combination therapy, and oncolytic viruses (OVs) have emerged as a safe and effecti...

Enzyvant

Enzyvant, a wholly owned subsidiary of Roivant Sciences, is a biotechnology company focused on developing transformative therapies for patients with rare diseases. Enzyvant leverages the Roivant platform to develop therapies that address high unmet medical needs while driving greater efficiency in research, clinical development, and commercialization. The ...

CORDENTAL Group

Based in Cincinnati, Ohio, CORDENTAL Group™ is a dental support organization that provides business support services to affiliated dental practices across the Mid-Atlantic, Midwestern and Southeastern United States. Founded upon strong guiding principles, CORDENTAL promotes a dentist-centric approach that allows dentists and their teams to concentrate...

Cannamedical® Pharma GmbH

At Cannamedical® Pharma GmbH we are committed to educating doctors, medical specialists and pharmacists thus helping them improve their patients’ quality of life. The high quality products by Cannamedical® focus on helping people with chronic illnesses to giving them a better quality of life with medicinal cannabis. We import and process only hi...

Tuesday 4th June 2019

UC Berkeley Extension

Founded in 1891, UC Berkeley Extension is the continuing education branch of the University of California, Berkeley. Today, Extension offers more than 2,000 courses each year, including online courses, along with more than 70 professional certificates and specialized programs of study. Free and low-cost public events are also frequently held as part of Ext...

Kashi Clinical Laboratories

Kashi Clinical Labs is a Portland-based company offering genetic testing for screening, diagnosis, prognosis, and monitoring. Kashi’s dedicated team provides high-quality, actionable results to physicians and patients. With Defy Your DNA, Kashi has expanded to offer consumer-initiated testing. Learn more at www.kashilab.com and www.defyyourdna.net. ...

Phathom Pharmaceuticals

Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late stage development for the treatm...

Monday 3rd June 2019

Aadi Bioscience, Inc.

Aadi is a clinical stage biopharmaceutical company led by Dr. Neil Desai, an inventor of ABRAXANE and the albumin-based technology platform. Aadi’s lead product nab-sirolimus (sirolimus albumin-bound nanoparticles for injectable suspension, ABI-009) is an mTOR inhibitor complexed with human albumin that has significantly higher tumor accumulation, mTO...

TransCure bioServices

TransCure bioServices SAS is a European CRO based in France offering pre-clinical in vivo pharmacology fee-for-services to international pharmaceutical, biotech and academic customers. Uniquely designed full human immune system and hu-liver mouse models provide predictive power for drug profiling and smarter drug candidate selection for immuno-oncology, in...


More From BioPortfolio on "Phase I Clinical Study in the Treatment of HER2-positive Recurrent or Metastatic Breast Cancer.∨derfield=score∨derval=desc"

Quick Search

Corporate Database Quicklinks